SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Traders are focused on LUNRs reported selection for NASAs CLPS 2.0 program and the dismissal of a bid protest, speculating that the awards could add to its backlog. The sharp rebound has fueled bullish and short-squeeze talk, while skeptics question the contract value and whether the rally will hold.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express shares are drawing attention after earnings beat expectations and management raised its outlook, but the stock fell amid plans to cut about 5% of its workforce as part of an AI-focused restructuring. Traders are split between viewing the selloff as an overreaction given resilient card spending and worrying about the job cuts, consumer strength, and softer revenue growth.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKKs rise is drawing attention alongside discussion of ARKs latest portfolio trades. Traders remain divided: critics point to the funds long-term underperformance and question Cathie Woods frequent rotations, while some see the recent strength as a potential technical recovery.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires Q3 results drew attention as operating earnings declined on weaker insurance underwriting, while share repurchases surged to a quarterly record. Traders are divided between concern about the earnings softness and viewing the buybacks as a sign of management confidence in Berkshires value.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers strong quarterly update, raised full-year outlook and NASA contract are driving attention alongside the sharp share-price move. Bulls welcome the growth and contract momentum, while skeptics point to weak margins, cash needs and past underperformance as reasons for caution.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimunes FDA-approved melanoma therapy is moving into commercialization, with traders focused on early prescriptions and launch execution as drivers of the sharp rebound. Bullish traders point to buying momentum and a possible short squeeze, while skeptics question whether adoption can justify the valuation amid cash-burn and execution risks.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is drawing attention after Northland upgraded the stock, citing C3 Code as a potential growth driver for building agentic AI applications; traders are debating whether the resulting move can hold. Bullish talk about call activity and short-squeeze potential contrasts with skepticism over the companys declining revenue and ability to turn AI demand into growth.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs quarterly results topped expectations and the company raised its full-year revenue outlook, driving a rally and renewed bullish talk about growth in diagnostics and data services. Traders are watching whether the earnings momentum can persist, while others point to sharp post-report swings and lingering concerns about valuation and hospital adoption.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention ahead of its quarterly report after a sharp pullback, with traders looking for guidance on AI-related networking demand and margins. The debate is whether data-center spending will sustain orders or whether project delays and tighter budgets will weaken demand; some see the selloff as overdone, while others remain wary after the analyst downgrade and recent weakness.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwires quarterly results are driving attention: revenue came in below expectations, while gross margins and backlog reached records and full-year guidance was reaffirmed. Traders are split between concern about converting backlog into revenue and optimism that improving margins and new defense-space awards support the longer-term outlook; the shares have swung sharply around the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million.
BeyondSpring (NASDAQ:BYSI) shares movedread more...

Liminatus Pharma Buys More Time, September 3 Deadline is Now the Catalyst

Liminatus Pharma (NASDAQ:LIMN) has cleared one immediate Nasdaq hurdle, but the clock is still running. The company announced that its common stock transferred from the Nasdaq Global Market to the Nasdaq Capital Market effective August 4, 2026, while the Nasdaq Hearings Panel granted Liminatus additional time to regain compliance with the exchange’s minimum bid price requirement. The new deadline is September 3, 2026, giving the company several more weeks to demonstrate compliance while allowing LIMN to continue trading on Nasdaq under its existing ticker.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million.
LENSAR (NASDAQ:LNSR) shares increased byread more...

Gainers

Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million.
Agape ATP (NASDAQ:ATPC) shares moved upwards byread more...

11 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million.
Liminatus Pharma (NASDAQ:LIMN)read more...

Liminatus Pharma (LIMN) Stock Is Trending Overnight  Here's Why it Spiked Over 30% in After-Hours Session (UPDATED)

Liminatus Pharma shares surged 30.49% in after-hours trading following an amended InnocsAI merger deal that speeds up closing.read more...

The Biotech Repricing Wave May Be Starting as Capital Pours into High-Impact Oncology Platforms

Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital raises, pipeline expansions, analyst initiations, and oncology breakthroughs reshapes momentum across the sector. $NTHI, $IMMX, $RLAY, $AKTX, $LIMN

Liminatus Pharma Is Trending Overnight  Here's Why LIMN Stock Surged Over 79% In After-Hours Session

Liminatus Pharma Inc. shares soared in after-hours trading after the company announced a merger agreement with InnocsAI LLC.read more...

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance 

Equity

The company had previously faced a notice for delayed filings but has since rectified the issue.

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.

Liminatus Pharma Inc. - Ordinary Shares - Class A

Bullish Sentiment

Shares of Liminatus Pharma, Inc. hit a record high on Wednesday after the company declared it had restored compliance with Nasdaq listing standards.The stock closed at $12.71, up 132.8% on Wednesday, with after-hours trading pushing the price further up 69.2% to $21.50.Liminatus received formal confirmation from Nasdaq on June 3, confirming the Nasdaq Listing Rule 5250(c)(1), which requires timely submission of reports to the U.S. Securities and Exchange Commission (SEC).&nbsp;The matter is now considered closed.Earlier on May 29, the company received a notice for not submitting its quarterly report on Form 10-Q for the quarter ended March 31, 2025, promptly.&nbsp;Liminatus submitted the delayed report on June 2, reinstating its SEC reporting compliance.Liminatus came public in early May following a Special Purpose Acquisition Company (SPAC) merger.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.While pointing out that the Liminatus Pharma stock held support, one user said they expected the rally to continue to the next day due to the relatively small float size of 150,000.<stembedurl>https://stocktwits.com/WealthQuest/message/616859995</stembedurl>Another user suggested that the company was preparing to spike to $35.<stembedurl>https://stocktwits.com/View2021/message/616842522</stembedurl>Since its May listing, the stock&nbsp;has risen 9.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Liminatus Pharma Inc.

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

LIMN Liminatus Pharma Inc.

Fundamentals

Latest LIMN News